Robust Put Option Volumes Signal Bearish Hedging
On 9 June 2026, Divis Laboratories emerged as one of the most actively traded stocks in the put options segment, with three key strike prices attracting significant volumes. The 6,400 strike put saw 1,613 contracts traded, generating a turnover of ₹50.92 lakhs and an open interest of 915 contracts. Meanwhile, the 6,600 strike put led the pack with 1,694 contracts traded, turnover of ₹1.35 crores, and open interest standing at 2,023 contracts. The 6,500 strike put was the most heavily traded, with 1,789 contracts exchanged, turnover of ₹90.18 lakhs, and a robust open interest of 3,588 contracts.
These figures highlight a pronounced inclination among traders to hedge or speculate on potential downside risks in Divis Laboratories’ stock price, which currently trades at ₹6,784. The concentration of open interest around the 6,500 and 6,600 strike prices suggests that market participants are positioning for a possible correction or increased volatility in the near term.
Expiry Patterns and Market Implications
The expiry date of 30 June 2026 is less than a month away, intensifying the focus on these put options. Historically, expiry weeks tend to bring heightened volatility as traders adjust or close positions. The elevated open interest and turnover in put options at strikes below the current market price indicate a strategic defensive stance, possibly reflecting concerns over sector-specific headwinds or broader market uncertainties.
Despite this, Divis Laboratories’ stock has demonstrated resilience. On 8 June, the stock outperformed its Pharmaceuticals & Biotechnology sector by 1.37%, closing with a 2.51% gain against the sector’s 0.85% and the Sensex’s 0.37% returns. The stock touched an intraday high of ₹6,669, marking a 2.27% rise, and traded with a weighted average price skewed towards the lower end of the day’s range, signalling mixed investor sentiment.
Technical Indicators and Investor Participation
From a technical perspective, Divis Laboratories is trading above its 5-day, 50-day, 100-day, and 200-day moving averages, though it remains below the 20-day moving average. This pattern suggests a short-term consolidation phase amid a longer-term uptrend. Notably, delivery volumes surged to 2.89 lakh shares on 8 June, a 9.45% increase over the five-day average, indicating rising investor participation and confidence in the stock’s liquidity.
Liquidity metrics further support active trading, with the stock’s average traded value enabling sizeable trades up to ₹6.26 crores without significant market impact. This liquidity is crucial for options traders seeking to enter or exit positions efficiently ahead of expiry.
Mojo Score and Analyst Ratings
Divis Laboratories currently holds a Mojo Score of 64.0, categorised as a 'Hold' rating by MarketsMOJO, reflecting a recent downgrade from a 'Buy' on 29 May 2026. This adjustment underscores a more cautious stance by analysts, likely influenced by the increased put option activity and the stock’s technical consolidation. The company remains a large-cap heavyweight with a market capitalisation of ₹1,72,687 crores, maintaining its status as a key sector constituent.
Investor Takeaways and Strategic Considerations
The surge in put option volumes at strike prices ranging from ₹6,400 to ₹6,600 ahead of the 30 June expiry suggests that investors are actively hedging against potential downside or positioning for volatility. While the stock’s recent outperformance and strong delivery volumes indicate underlying strength, the technical signals and options market activity warrant a measured approach.
Investors should closely monitor price action around the 20-day moving average and open interest trends in the coming weeks. The elevated open interest in puts may also present opportunities for contrarian strategies if the stock sustains its uptrend, as unwinding of bearish positions could fuel further gains.
In summary, Divis Laboratories is at a critical juncture where bullish fundamentals coexist with cautious market sentiment, as reflected in the options market. This dynamic environment calls for vigilant risk management and a balanced view on the stock’s near-term prospects.
